✦ LIBER ✦

Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C

✍ Scribed by Sadeghi, Farzin; Bokharaei-Salim, Farah; Salehi-Vaziri, Mostafa; Monavari, Seyed Hamidreza; Alavian, Seyed Moayed; Salimi, Shima; Vahabpour, Rouhollah; Keyvani, Hossein

Book ID: 124084290
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 134 KB
Volume: 86
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.23985

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early response to IFN induction therapy,

Early response to IFN induction therapy, induction + ribavirin and IFN + ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1

✍ Bellobuono, Antonio A.; Tempini, Silvana S.; Ideo, Gian Marco G.; Brasca, Paola 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 161 KB

PIN42 Cost-Effectiveness-Analysis of the

PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

✍ M. Said; A. Dragosits; E. Walter 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Comparison between IFN induction, induct

Comparison between IFN induction, induction+ ribavirin and IFN+ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1

✍ A. Bellobuono; S. Tempini; G.M. Idéo; D. Grimoldi; P. Brasca; G. Idéo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 134 KB

IFN-stimulated Gene Expression Is a Usef

IFN-stimulated Gene Expression Is a Useful Potential Molecular Marker of Response to Antiviral Treatment with Peg-IFNα 2b and Ribavirin in Patients with Hepatitis C Virus Genotype 1

✍ María Sara Sixtos-Alonso; Fausto Sánchez-Muñoz; Juan Francisco Sánchez-Ávila; Ro 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Comparison between combination therapy w

Comparison between combination therapy with peg-interferon alfa-2A plus ribavirin and peg-interferon alfa-2B plus ribavirin in the treatment of chronic hepatitis C

✍ M. Capanni; M.R. Biagini; S. Nanni; E. Lorefice; M. Paci; M.C. Benini; E. Gai; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A health economic model to assess the co

A health economic model to assess the cost-effectiveness of PEG IFN α-2a and ribavirin in patients with mild chronic hepatitis C

✍ S. Gerkens; M. Nechelput; L. Annemans; B. Peraux; M. Mouchart; C. Beguin; Y. Hor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB